Showing results (41-50 of 3,882) with videos related to
Sort By:
Pageof 389
Expert Opinion on Investigational Drugs|September 15, 2010
High-dose treosulfan in conditioning prior to hematopoietic stem cell transplantationFranciszek K Główka, Michał Romański, Jacek WachowiakExpert Opinion on Investigational Drugs|August 17, 2010
11beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetesStuart A Morgan, Jeremy W TomlinsonExpert Opinion on Investigational Drugs|July 29, 2010
Novel investigational drugs for basal cell carcinomaPo-Lin So, Jean Y Tang, Ervin H EpsteinExpert Opinion on Investigational Drugs|November 5, 2010
New drugs in advanced non-small-cell lung cancer: searching for the correct clinical developmentMassimo Di Maio, Alessandro Morabito, Maria Carmela Piccirillo, et al.Expert Opinion on Investigational Drugs|April 2, 2011
From targeted therapy in ovarian cancer to personalizing therapy for ovarian cancerCésar Gómez-Raposo, Marta Mendiola, Jorge Barriuso, et al.Expert Opinion on Investigational Drugs|March 23, 2011
Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsiaJan Tack, Pieter JanssenExpert Opinion on Investigational Drugs|April 8, 2011
Paclitaxel poliglumex for ovarian cancerVijaya L Galic, Jason D Wright, Sharyn N Lewin, et al.Expert Opinion on Investigational Drugs|March 30, 2011
Angiogenesis-related molecular targets in esophageal cancerLiu Hong, Shujun Li, Yu Han, et al.Expert Opinion on Investigational Drugs|March 29, 2011
The Syk kinase as a therapeutic target in leukemia and lymphomaDimitar G Efremov, Luca LaurentiExpert Opinion on Investigational Drugs|February 15, 2011
XL184 (cabozantinib) for medullary thyroid carcinomaCosimo Durante, Diego Russo, Antonella Verrienti, et al.Pageof 389